Search

Key U.S. senator remains concerned over ChemChina-Syngenta deal

BEIJING (Reuters) - A powerful U.S. senator said he is concerned that state-owned ChemChina, which is buying Swiss crop protection and seed group Syngenta for $43 billion, could use U.S. sovereign immunity laws to shield itself from claims in U.S. courts.

Key U.S. senator remains concerned over ChemChina-Syngenta deal
Read More


Bagikan Berita Ini

0 Response to "Key U.S. senator remains concerned over ChemChina-Syngenta deal"

Posting Komentar

Diberdayakan oleh Blogger.